96 related articles for article (PubMed ID: 28266739)
1. Decreased expression of SOX7 induces cell proliferation and invasion and correlates with poor prognosis in oral squamous cell carcinoma.
Oh KY; Hong KO; Huh YS; Lee JI; Hong SD
J Oral Pathol Med; 2017 Oct; 46(9):752-758. PubMed ID: 28266739
[TBL] [Abstract][Full Text] [Related]
2. Loss of keratin 8 phosphorylation leads to increased tumor progression and correlates with clinico-pathological parameters of OSCC patients.
Alam H; Gangadaran P; Bhate AV; Chaukar DA; Sawant SS; Tiwari R; Bobade J; Kannan S; D'cruz AK; Kane S; Vaidya MM
PLoS One; 2011; 6(11):e27767. PubMed ID: 22114688
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptors 1 and 4 combined with lymph node metastasis predicts poor prognosis in oral cancer.
Gu ZY; Zhou R; Hong D; Han Y; Wang LZ; Li J; Zhang ZY; Shi CJ
Oral Dis; 2024 Apr; 30(3):1004-1017. PubMed ID: 36938639
[TBL] [Abstract][Full Text] [Related]
4. [Expression and prognostic value of IL-6 and β-catenin in oral squamous cell carcinoma].
Dong LS; Tang J; Cheng W; Ran JX; Liu ZB; Li YD
Shanghai Kou Qiang Yi Xue; 2023 Jun; 32(3):280-286. PubMed ID: 37803984
[TBL] [Abstract][Full Text] [Related]
5. Leukemia inhibitory factor produced by fibroblasts within tumor stroma participates in invasion of oral squamous cell carcinoma.
Ohata Y; Tsuchiya M; Hirai H; Yamaguchi S; Akashi T; Sakamoto K; Yamaguchi A; Ikeda T; Kayamori K
PLoS One; 2018; 13(2):e0191865. PubMed ID: 29444110
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA PANDAR overexpression serves as a poor prognostic biomarker in oral squamous cell carcinoma.
Huang Z; Sang T; Zheng Y; Wu J
Int J Clin Exp Pathol; 2018; 11(5):2728-2734. PubMed ID: 31938389
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 5 expression predicts the progression of oral squamous cell carcinoma.
Shie WY; Cheng SJ; Chen KC; Tang CC; Peng HH; Ko HH; Hou HH; Elizabeth Chou HY
J Formos Med Assoc; 2024 Mar; 123(3):390-399. PubMed ID: 37704482
[TBL] [Abstract][Full Text] [Related]
8. Impact of worst pattern of invasion on prognosis of oral squamous cell carcinoma: a systematic review and meta-analysis.
Binmadi NO; Mohamed YA
J Int Med Res; 2023 Oct; 51(10):3000605231206260. PubMed ID: 37871621
[TBL] [Abstract][Full Text] [Related]
9. Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells.
Lin LQ; Lv SY; Ren HZ; Li RR; Li L; Pang YQ; Wang J
Kaohsiung J Med Sci; 2024 Apr; 40(4):348-359. PubMed ID: 38243370
[TBL] [Abstract][Full Text] [Related]
10. Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral Cancer.
Reddi KK; Zhang W; Shahrabi-Farahani S; Anderson KM; Liu M; Kakhniashvili D; Wang X; Zhang YH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473906
[TBL] [Abstract][Full Text] [Related]
11. Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase Acts as a Tumor Suppressor in Oral Squamous Cell Carcinoma.
Etemad-Moghadam S; Mohammadpour H; Emami Razavi A; Alaeddini M
Appl Immunohistochem Mol Morphol; 2024 May-Jun 01; 32(5):249-253. PubMed ID: 38602289
[TBL] [Abstract][Full Text] [Related]
12. BMP-2 promotes oral squamous carcinoma cell invasion by inducing CCL5 release.
Kim MJ; Kim KM; Kim J; Kim KN
PLoS One; 2014; 9(10):e108170. PubMed ID: 25271422
[TBL] [Abstract][Full Text] [Related]
13. Peptidomics-Driven Strategy Reveals Peptides and Predicted Proteases Associated With Oral Cancer Prognosis.
Neves LX; Granato DC; Busso-Lopes AF; Carnielli CM; Patroni FMS; De Rossi T; Oliveira AK; Ribeiro ACP; Brandão TB; Rodrigues AN; Lacerda PA; Uno M; Cervigne NK; Santos-Silva AR; Kowalski LP; Lopes MA; Paes Leme AF
Mol Cell Proteomics; 2021; 20():100004. PubMed ID: 33578082
[TBL] [Abstract][Full Text] [Related]
14. Heat-killed Prevotella intermedia promotes the progression of oral squamous cell carcinoma by inhibiting the expression of tumor suppressors and affecting the tumor microenvironment.
Zhou Y; Qin Y; Ma J; Li Z; Heng W; Zhang L; Liu H; Li R; Zhang M; Peng Q; Ye P; Duan N; Liu T; Wang W; Wang X
Exp Hematol Oncol; 2024 Mar; 13(1):33. PubMed ID: 38515216
[TBL] [Abstract][Full Text] [Related]
15. PPT1 Promotes Growth and Inhibits Ferroptosis of Oral Squamous Cell Carcinoma Cells.
Luo Q; Hu S; Tang Y; Yang D; Chen Q
Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38299399
[TBL] [Abstract][Full Text] [Related]
16. Frequency of cd44 expression in diagnosed cases of oral Epithelial dysplasia and squamous cell carcinoma.
Momin Z; Rahat N; Shahzad H; Umair M; Kaleemi R; Khursheed A
J Ayub Med Coll Abbottabad; 2023; 35(Suppl 1)(4):S762-S768. PubMed ID: 38406907
[TBL] [Abstract][Full Text] [Related]
17. Serpin peptidase inhibitor, clade E, member 2 is associated with malignant progression and clinical prognosis in oral squamous cell carcinoma.
Chuang HW; Lin LH; Ji DD; Fu TY; Lee HS; Yang YF; Tseng HC; Hsia KT
J Dent Sci; 2024 Jan; 19(1):70-78. PubMed ID: 38303830
[TBL] [Abstract][Full Text] [Related]
18. Tumor infiltrating neutrophil microabscess in OSCC: A poorly understood histopathologic prognosticator.
Sarode G; Ghone U; Sengupta N; Anand R; Sarode SC
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101609. PubMed ID: 37619671
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of GLS2 indicates a poor prognosis and correlates with clinicopathological features of oral squamous cell carcinoma.
Kannan B; Pandi C; Pandi A; Jayaseelan VP; Murugan M S; Arumugam P
Int J Oral Maxillofac Surg; 2024 Feb; ():. PubMed ID: 38342749
[TBL] [Abstract][Full Text] [Related]
20. Low expression of interleukin-1 receptor antagonist correlates with poor prognosis via promoting proliferation and migration and inhibiting apoptosis in oral squamous cell carcinoma.
Ding Y; Yi J; Shan Y; Gu J; Sun Z; Lin J
Cytokine; 2024 Apr; 179():156595. PubMed ID: 38581865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
